Literature DB >> 26176693

Severe acute liver failure and thyrotoxicosis: an unusual association.

Adrian Sousa Domínguez1.   

Abstract

Thyrotoxicosis is defined as the clinical syndrome resulting from the excess of thyroid hormones in the organism. It has several causes and a wide range of clinical manifestations, from mild tachycardia up to multiple organ failure. Although it is not unusual that patients with thyroid dysfunction have abnormal liver-function test these are usually mild and the initial presentation as severe liver failure is exceptional. We present a case report of a patient who developed a severe acute liver failure due to a non-controlled hyperthyroidsm. Also we conducted a review of all similar cases reported to date in the literature.

Entities:  

Year:  2015        PMID: 26176693     DOI: 10.17235/reed.2015.3607/2014

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  4 in total

Review 1.  Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases.

Authors:  Qianyu Tang; Min Zeng; Linxi Chen; Nian Fu
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  Therapeutic plasma exchange and continuous renal replacement therapy for severe hyperthyroidism and multi-organ failure: A case report.

Authors:  Jun-Hui Ba; Ben-Quan Wu; Yan-Hong Wang; Yun-Feng Shi
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

3.  Risk factors for underlying comorbidities and complications in patients with hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Wei-Zhen Weng; Jun-Feng Chen; Xiao-Hua Peng; Miao Huang; Jing Zhang; Jing Xiong; Hui-Juan Cao; Bing-Liang Lin
Journal:  Epidemiol Infect       Date:  2022-07-05       Impact factor: 4.434

4.  A case of acute-on-chronic liver failure promoted by thyrotoxicosis triggered due to iodinated contrast media exposure.

Authors:  Yan-Ting Ye; Jing-Sun Jiang; Lin-Jie Guo; Cheng-Wei Tang; Li-Bin Huang
Journal:  Chin Med J (Engl)       Date:  2020-03-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.